Therapeutic modulation of inflammasome pathways - Chauhan - 2020

Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

Involvement of inflammasomes in tumor microenvironment and tumor therapies, Journal of Hematology & Oncology

Frontiers Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis

Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis - ScienceDirect

PDF) Therapeutic modulation of inflammasome pathways

The role of Nod-like receptor protein 3 inflammasome activated by ion channels in multiple diseases

IJMS, Free Full-Text

Targeting the Inflammasome in Cardiovascular Disease - ScienceDirect

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report

Frontiers The role of NLRP3 inflammasome in digestive system malignancy

Frontiers Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis

Therapeutic modulation of inflammasome pathways